Varex Imaging (NASDAQ:VREX) Receives $16.17 Average PT from Brokerages

Varex Imaging (NASDAQ:VREX) has received an average rating of “Moderate Buy” from the five analysts that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $16.1667.

VREX has been the topic of a number of recent analyst reports. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research report on Wednesday, June 24th.

Varex Imaging Price Performance

NASDAQ VREX opened at $10.92 on Friday. The stock’s 50-day moving average price is $10.44 and its 200-day moving average price is $11.63. The company has a quick ratio of 1.43, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. Varex Imaging has a 52 week low of $6.76 and a 52 week high of $14.56. The company has a market capitalization of $459.73 million, a P/E ratio of -5.46 and a beta of 0.90.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The company had revenue of $216.00 million for the quarter, compared to analysts’ expectations of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. On average, equities research analysts predict that Varex Imaging will post 0.93 earnings per share for the current year.

Institutional Investors Weigh In On Varex Imaging

Institutional investors have recently bought and sold shares of the business. Franklin Resources Inc. raised its holdings in Varex Imaging by 2.2% during the fourth quarter. Franklin Resources Inc. now owns 57,720 shares of the company’s stock valued at $672,000 after acquiring an additional 1,261 shares during the period. SG Americas Securities LLC boosted its stake in shares of Varex Imaging by 4.4% in the first quarter. SG Americas Securities LLC now owns 30,202 shares of the company’s stock worth $320,000 after acquiring an additional 1,272 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of Varex Imaging by 10.4% in the second quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after acquiring an additional 1,442 shares during the period. Deutsche Bank AG grew its position in shares of Varex Imaging by 5.7% during the fourth quarter. Deutsche Bank AG now owns 27,459 shares of the company’s stock worth $320,000 after purchasing an additional 1,477 shares in the last quarter. Finally, Comerica Bank grew its position in shares of Varex Imaging by 9.3% during the third quarter. Comerica Bank now owns 20,363 shares of the company’s stock worth $253,000 after purchasing an additional 1,726 shares in the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.